Huntsman Corporation 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated June 27, 2007, reports on an event occurring on June 26, 2007. Huntsman Corporation (the "Company") announced the entry into a definitive Agreement and Plan of Merger with Basell AF ("Basell") and its wholly-owned subsidiary, BI Acquisition Holdings Limited ("Merger Sub").
Key Financial Metrics and Transaction Terms
This filing details a proposed acquisition rather than periodic financial performance. Key financial terms include:
- Merger Consideration: $25.25 in cash per outstanding share of Common Stock.
- Equity Treatment: Restricted stock, restricted stock units, and phantom stock will convert to the right to receive the Merger Consideration. All outstanding stock options will vest immediately prior to the effective time, with holders receiving the cash excess of the Merger Consideration over the exercise price.
- Termination Fee: The Company may be required to pay a termination fee of $200 million under specified circumstances, such as termination due to a Superior Proposal.
- Financing: The transaction is not subject to a financing condition.
The filing text does not provide current revenue, profit, cash flow, margins, debt, or liquidity metrics for the Company.
Material Changes and Conditions
The primary material change is the agreement to be acquired by Basell. The transaction is subject to several conditions, including:
- Approval by Huntsman Corporation stockholders.
- Expiration or termination of waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
- Foreign competition approvals.
- Other customary closing conditions.
Basell has secured a Voting Agreement with HMP Equity Trust and other stockholders owning approximately 58.6% of the Common Stock to vote in favor of the merger.
Guidance, Outlook, and Risks
Outlook: The parties expect to close the transaction in the fourth quarter of 2007.
Risks and Contingencies: The filing includes cautionary statements regarding forward-looking information. Risks include actions by regulatory authorities, failure to satisfy closing conditions, and the potential for other bidders. The Company disclaims any obligation to update these statements.
Management Commentary: The Board of Directors approved the Agreement on the unanimous recommendation of a transaction committee comprised entirely of independent directors.
Investor Verification Checklist
- Verify the final approval status of the merger by Huntsman stockholders.
- Monitor regulatory approvals, specifically under the Hart-Scott-Rodino Act and foreign competition laws.
- Review the upcoming proxy statement for detailed information on the merger and potential conflicts of interest.
- Confirm the final closing date, as the current expectation is the fourth quarter of 2007.
- Assess the risk of a Superior Proposal emerging, which could trigger the $200 million termination fee.